TELA BIO INC (TELA)
US8723811084 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to TELA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.02. This target is 265.98% above the current price.
TELA was analyzed by 11 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about TELA.
In the previous month the buy percentage consensus was at a similar level.
TELA was analyzed by 11 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-08 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-10-04 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-13 | Lake Street | Maintains | Buy -> Buy |
| 2024-08-13 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-08-13 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-08-13 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2024-07-25 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-10 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-22 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-03-22 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-12-27 | Lake Street | Reiterate | Buy -> Buy |
| 2023-11-10 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2023-03-28 | Canaccord Genuity | Reiterate | Buy |
| 2023-03-22 | JMP Securities | Reiterate | Market Outperform |
| 2022-11-10 | JMP Securities | Maintains | Market Outperform |
| 2022-11-10 | Piper Sandler | Maintains | Overweight |